Extrachromosomal Circular DNA: A New Target in Cancer

Pan Wu(Central South University), Wei Xiong(Central South University), Can Guo(Central South University), Fang Xiong(Central South University), Zhaoyang Zeng(Gansu University of Traditional Chinese Medicine), Ming Zhou(Central South University), Wenling Zhang(Central South University), Hong-Li Zeng(First Affiliated Hospital of University of South China), Guiyuan Li(Central South University), Lingyun Liu(University of South China), Yong Li(Baylor College of Medicine), Shanshan Zhang(Central South University), Yuhang Liu(Central South University), Fuyan Wang(W. L. Gore & Associates (Germany)), Xuyu Zu(Tsinghua University), Zhaojian Gong(Central South University), He Huang(Xiangya Hospital Central South University), Ruijia Zhou(Central South University)
Frontiers in Oncology
April 14, 2022
10.3389/fonc.2022.814504
Cited by 31

Related Papers

Neoantigen vaccine: an emerging tumor immunotherapy
|Molecular Cancer|2019|713
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677
Effects of environmental pollutants on gut microbiota
|Environmental Pollution|2017|662
Regulatory mechanisms of PD-1/PD-L1 in cancers
|Molecular Cancer|2024|619
MicroRNA-125b Confers the Resistance of Breast Cancer Cells to Paclitaxel through Suppression of Pro-apoptotic Bcl-2 Antagonist Killer 1 (Bak1) Expression
|Journal of Biological Chemistry|2010|429